Manganese Enhanced MRI for Use in Studying Neurodegenerative Diseases

Overview

Journal Front Neural Circuits

Date 2019 Jan 23

PMID 30666190

Citations 12

Authors

Galit Saar

Alan P Koretsky

Affiliations

Soon will be listed here.

Abstract

MRI has been extensively used in neurodegenerative disorders, such as Alzheimer's disease (AD), frontal-temporal dementia (FTD), mild cognitive impairment (MCI), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). MRI is important for monitoring the neurodegenerative components in other diseases such as epilepsy, stroke and multiple sclerosis (MS). Manganese enhanced MRI (MEMRI) has been used in many preclinical studies to image anatomy and cytoarchitecture, to obtain functional information in areas of the brain and to study neuronal connections. This is due to Mn ability to enter excitable cells through voltage gated calcium channels and be actively transported in an anterograde manner along axons and across synapses. The broad range of information obtained from MEMRI has led to the use of Mn in many animal models of neurodegeneration which has supplied important insight into brain degeneration in preclinical studies. Here we provide a brief review of MEMRI use in neurodegenerative diseases and in diseases with neurodegenerative components in animal studies and discuss the potential translation of MEMRI to clinical use in the future.

Citing Articles

Aqueous Dispersion of Manganese-Zinc Ferrite Nanoparticles Protected by PEG as a T MRI Temperature Contrast Agent.

Lachowicz D, Kmita A, Gajewska M, Trynkiewicz E, Przybylski M, Russek S Int J Mol Sci. 2023; 24(22).

PMID: 38003646 PMC: 10671015. DOI: 10.3390/ijms242216458.

tracing of the ascending vagal projections to the brain with manganese enhanced magnetic resonance imaging.

Oleson S, Cao J, Wang X, Liu Z Front Neurosci. 2023; 17:1254097.

PMID: 37781260 PMC: 10540305. DOI: 10.3389/fnins.2023.1254097.

Ensemble Model for Diagnostic Classification of Alzheimer's Disease Based on Brain Anatomical Magnetic Resonance Imaging.

Khan Y, Kaushik B, Chowdhary C, Srivastava G Diagnostics (Basel). 2022; 12(12).

PMID: 36553199 PMC: 9777931. DOI: 10.3390/diagnostics12123193.

Magnetic Resonance Imaging Investigation of Neuroplasticity After Ischemic Stroke in Tetramethylpyrazine-Treated Rats.

Feng X, Lei J, Li M, Zhan Y, Yang L, Lu Y Front Pharmacol. 2022; 13:851746.

PMID: 35559236 PMC: 9086494. DOI: 10.3389/fphar.2022.851746.

Effect of Neurorepair for Motor Functional Recovery Enhanced by Total Saponins From Maxim. Treatment in a Rat Model of Focal Ischemia.

Yang L, Lei J, Ouyang J, Li M, Zhan Y, Feng X Front Pharmacol. 2021; 12:763181.

PMID: 34955834 PMC: 8703076. DOI: 10.3389/fphar.2021.763181.

References

Poisnel G, Herard A, El Tannir El Tayara N, Bourrin E, Volk A, Kober F . Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease. Neurobiol Aging. 2011; 33(9):1995-2005. PMC: 3666917. DOI: 10.1016/j.neurobiolaging.2011.09.026. View

Kwon D, Kim J, Oh S, Jeong H, Park S, Oh E . Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol. 2012; 71(2):267-77. DOI: 10.1002/ana.22592. View

Crossgrove J, Zheng W . Manganese toxicity upon overexposure. NMR Biomed. 2004; 17(8):544-53. PMC: 3980863. DOI: 10.1002/nbm.931. View

Luo F, Rustay N, Ebert U, Hradil V, Cole T, Llano D . Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease. Neurobiol Aging. 2010; 33(5):933-44. DOI: 10.1016/j.neurobiolaging.2010.08.005. View

Wang J, You H, Liu J, Ni D, Zhang Z, Guan J . Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am J Neuroradiol. 2011; 32(4):677-81. PMC: 7965889. DOI: 10.3174/ajnr.A2350. View

Alvestad S, Goa P, Qu H, Risa O, Brekken C, Sonnewald U . In vivo mapping of temporospatial changes in manganese enhancement in rat brain during epileptogenesis. Neuroimage. 2007; 38(1):57-66. DOI: 10.1016/j.neuroimage.2007.07.027. View

Weng J, Tikhonova M, Chen J, Shen M, Meng W, Chang Y . Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study. Behav Brain Res. 2016; 305:126-39. DOI: 10.1016/j.bbr.2016.02.034. View

Aschner J, Anderson A, Slaughter J, Aschner M, Steele S, Beller A . Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition. Am J Clin Nutr. 2015; 102(6):1482-9. PMC: 4658463. DOI: 10.3945/ajcn.115.116285. View

Nopoulos P, Aylward E, Ross C, Johnson H, Magnotta V, Juhl A . Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis. 2010; 40(3):544-54. PMC: 2955824. DOI: 10.1016/j.nbd.2010.07.014. View

10.

Yu X, Zou J, Babb J, Johnson G, Sanes D, Turnbull D . Statistical mapping of sound-evoked activity in the mouse auditory midbrain using Mn-enhanced MRI. Neuroimage. 2007; 39(1):223-30. PMC: 2473867. DOI: 10.1016/j.neuroimage.2007.08.029. View

11.

Hsu Y, Lee W, Chang C . Multiparametric MRI evaluation of kainic acid-induced neuronal activation in rat hippocampus. Brain. 2007; 130(Pt 12):3124-34. DOI: 10.1093/brain/awm207. View

12.

Yoo A, Verduzco L, Schaefer P, Hirsch J, Rabinov J, Gonzalez R . MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke. 2009; 40(6):2046-54. PMC: 2709767. DOI: 10.1161/STROKEAHA.108.541656. View

13.

Smith K, Peethumnongsin E, Lin H, Zheng H, Pautler R . Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse Models. Magn Reson Insights. 2010; 4:11-18. PMC: 2927830. DOI: 10.4137/mri.s5237. View

14.

Macdonald I, DeBay D, Reid G, OLeary T, Jollymore C, Mawko G . Early detection of cerebral glucose uptake changes in the 5XFAD mouse. Curr Alzheimer Res. 2014; 11(5):450-60. PMC: 4082185. DOI: 10.2174/1567205011666140505111354. View

15.

Dedeurwaerdere S, Fang K, Chow M, Shen Y, Noordman I, van Raay L . Manganese-enhanced MRI reflects seizure outcome in a model for mesial temporal lobe epilepsy. Neuroimage. 2012; 68:30-8. DOI: 10.1016/j.neuroimage.2012.11.054. View

16.

Chen C, Zechariah A, Hsu Y, Chen H, Yang L, Chang C . Neuroaxonal ion dyshomeostasis of the normal-appearing corpus callosum in experimental autoimmune encephalomyelitis. Exp Neurol. 2008; 210(2):322-30. DOI: 10.1016/j.expneurol.2007.11.008. View

17.

Allegrini P, Wiessner C . Three-dimensional MRI of cerebral projections in rat brain in vivo after intracortical injection of MnCl2. NMR Biomed. 2003; 16(5):252-6. DOI: 10.1002/nbm.834. View

18.

Lehericy S, Bardinet E, Poupon C, Vidailhet M, Francois C . 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord. 2014; 29(13):1574-81. DOI: 10.1002/mds.26043. View

19.

Nanetti L, Contarino V, Castaldo A, Sarro L, Bachoud-Levi A, Giavazzi M . Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease. Parkinsonism Relat Disord. 2018; 51:17-23. DOI: 10.1016/j.parkreldis.2018.02.033. View

20.

Kerchner G, Hess C, Hammond-Rosenbluth K, Xu D, Rabinovici G, Kelley D . Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology. 2010; 75(15):1381-7. PMC: 3013485. DOI: 10.1212/WNL.0b013e3181f736a1. View